Doxorubicin

BCL2 apoptosis regulator ; Homo sapiens







264 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 32924840 Deciphering the interaction of puerarin with cancer macromolecules: An in silico investigation. 2022 Feb 2
2 34719826 Loperamide potentiates doxorubicin sensitivity in triple-negative breast cancer cells by targeting MDR1 and JNK and suppressing mTOR and Bcl-2: In vitro and molecular docking study. 2022 Jan 1
3 34764434 BCL2 super-expressor diffuse large B-cell lymphoma: a distinct subgroup associated with poor prognosis. 2022 Apr 1
4 35210368 PKC is an indispensable factor in promoting environmental toxin chromium-mediated transformation and drug resistance. 2022 Feb 24 1
5 35216449 Employing CRISPR-Cas9 to Generate CD133 Synthetic Lethal Melanoma Stem Cells. 2022 Feb 20 1
6 35579133 Enzalutamide Overcomes Dihydrotestosterone Induced Chemo-Resistance In Triple-Negative Breast Cancer Cells via Apoptosis. 2022 May 9 2
7 33022330 Photoimmunotherapy with cetuximab-conjugated gold nanorods reduces drug resistance in triple negative breast cancer spheroids with enhanced infiltration of tumor-associated macrophages. 2021 Jan 10 1
8 33152391 Combination of cancer-specific prodrug nanoparticle with Bcl-2 inhibitor to overcome acquired drug resistance. 2021 Feb 10 1
9 33390801 USP37 downregulation elevates the Chemical Sensitivity of Human Breast Cancer Cells to Adriamycin. 2021 1
10 33411349 CD44 enhances adriamycin resistance in chronic myelogenous leukaemia cells K562. 2021 Oct 1
11 33443508 Combination of mitochondria targeting doxorubicin with Bcl-2 function-converting peptide NuBCP-9 for synergistic breast cancer metastasis inhibition. 2021 Feb 7 1
12 33509300 Epigenetic immunomodulatory effect of eugenol and astaxanthin on doxorubicin cytotoxicity in hormonal positive breast Cancer cells. 2021 Jan 28 1
13 33639139 Anti-CD19 mAb modified mesoporous titanium dioxide as exclusively targeting vector for efficient B-lymphoblastic leukemia therapy. 2021 Jul 1
14 33721171 The effect of bee bread (Perga) with chemotherapy on MDA-MB-231 cells. 2021 Mar 1
15 33828027 MicroRNA-221 Upregulates the Expression of P-gp and Bcl-2 by Activating the Stat3 Pathway to Promote Doxorubicin Resistance in Osteosarcoma Cells. 2021 Jun 1 3
16 33850567 Hydroxyl safflower yellow B combined with doxorubicin inhibits the proliferation of human breast cancer MCF-7 cells. 2021 May 1
17 33923922 Mangiferin Inhibits Apoptosis in Doxorubicin-Induced Vascular Endothelial Cells via the Nrf2 Signaling Pathway. 2021 Apr 20 1
18 34111614 Evidences for the mechanism of Shenmai injection antagonizing doxorubicin-induced cardiotoxicity. 2021 Jul 15 1
19 34120620 Biomimetic nanotherapy: core-shell structured nanocomplexes based on the neutrophil membrane for targeted therapy of lymphoma. 2021 Jun 13 1
20 34132104 Thymoquinone and its nanoformulation attenuate colorectal and breast cancers and alleviate doxorubicin-induced cardiotoxicity. 2021 Jun 16 1
21 34153682 Knockout of FosB gene changes drug sensitivity and invasion activity via the regulation of Bcl-2, E-cadherin, β-catenin, and vimentin expression. 2021 Aug 27 2
22 34573088 Betulinic Acid-Doxorubicin-Drug Combination Induced Apoptotic Death via ROS Stimulation in a Relapsed AML MOLM-13 Cell Model. 2021 Sep 14 2
23 34608124 Severe cellular stress activates apoptosis independently of p53 in osteosarcoma. 2021 Oct 4 2
24 34732441 Clinicopathologic and Prognostic Significance of Bruton's Tyrosine Kinase Expression in Diffuse Large B-Cell Lymphoma. 2021 Nov 1
25 30741049 Biotin anchored nanostructured lipid carriers for targeted delivery of doxorubicin in management of mammary gland carcinoma through regulation of apoptotic modulator. 2020 Mar 1
26 31498707 MicroRNA-483-3p Promotes Proliferation, Migration, and Invasion and Induces Chemoresistance of Wilms' Tumor Cells. 2020 Mar-Apr 1
27 31566215 Impaired NF-κB signalling underlies cyclophilin D-mediated mitochondrial permeability transition pore opening in doxorubicin cardiomyopathy. 2020 May 1 2
28 31753388 Doxorubicin-loaded functionalized selenium nanoparticles for enhanced antitumor efficacy in cervical carcinoma therapy. 2020 Jan 3
29 31840727 Mitochondria-targeted tetrahedral DNA nanostructures for doxorubicin delivery and enhancement of apoptosis. 2020 Jan 22 2
30 32128952 Enhanced anticancer potency of doxorubicin in combination with curcumin in gastric adenocarcinoma. 2020 Jun 2
31 32145585 Kaempferol protects mitochondria and alleviates damages against endotheliotoxicity induced by doxorubicin. 2020 Jun 1
32 32241443 Indomethacin-grafted and pH-sensitive dextran micelles for overcoming inflammation-mediated multidrug resistance in breast cancer. 2020 Jun 1 1
33 32340377 Arctigenin Enhances the Cytotoxic Effect of Doxorubicin in MDA-MB-231 Breast Cancer Cells. 2020 Apr 23 1
34 32377726 Doxorubicin selectively induces apoptosis through the inhibition of a novel isoform of Bcl‑2 in acute myeloid leukaemia MOLM‑13 cells with reduced Beclin 1 expression. 2020 Jul 5
35 32422307 Thymoquinone potentiates miR-16 and miR-375 expressions in hepatocellular carcinoma. 2020 Aug 1 1
36 32606309 Quantitative analysis of tumor-specific BCL2 expression in DLBCL: refinement of prognostic relevance of BCL2. 2020 Jun 30 1
37 32635973 Anti-CD19 mAb-conjugated human serum albumin nanoparticles effectively deliver doxorubicin to B-lymphoblastic leukemia cells. 2020 Jul 1 1
38 32848792 Antianemia Drug Roxadustat (FG-4592) Protects Against Doxorubicin-Induced Cardiotoxicity by Targeting Antiapoptotic and Antioxidative Pathways. 2020 1
39 32919690 Folic acid-modified bovine serum albumin nanoparticles with doxorubicin and chlorin e6 for effective combinational chemo-photodynamic therapy. 2020 Dec 3
40 33121131 O-GlcNAc Transferase Inhibitor Synergistically Enhances Doxorubicin-Induced Apoptosis in HepG2 Cells. 2020 Oct 27 1
41 33193866 Enhanced anticancer effect of doxorubicin by TPGS-coated liposomes with Bcl-2 siRNA-corona for dual suppression of drug resistance. 2020 Sep 5
42 30535663 MiR-15b-5p is Involved in Doxorubicin-Induced Cardiotoxicity via Inhibiting Bmpr1a Signal in H9c2 Cardiomyocyte. 2019 Jun 1
43 30880468 Anti-tumour effects of red blood cell membrane-camouflaged black phosphorous quantum dots combined with chemotherapy and anti-inflammatory therapy. 2019 Dec 1
44 30924664 Hyaluronan-Stabilized Redox-Sensitive Nanoassembly for Chemo-Gene Therapy and Dual T1/T2 MR Imaging in Drug-Resistant Breast Cancer Cells. 2019 May 6 2
45 30965082 Design, computational studies, synthesis and biological evaluation of thiazole-based molecules as anticancer agents. 2019 Jun 15 1
46 31127617 Effect of nucleolin on adriamycin resistance via the regulation of B-cell lymphoma 2 expression in Burkitt's lymphoma cells. 2019 Dec 1
47 31202781 Oridonin synergistically enhances the anti-tumor efficacy of doxorubicin against aggressive breast cancer via pro-apoptotic and anti-angiogenic effects. 2019 Aug 1
48 31235998 MiR-34a overexpression enhances the inhibitory effect of doxorubicin on HepG2 cells. 2019 Jun 14 1
49 31319070 Nicorandil prevents doxorubicin-induced human umbilical vein endothelial cell apoptosis. 2019 Sep 15 1
50 31333784 A medicinal and edible formula YH0618 ameliorates the toxicity induced by Doxorubicin via regulating the expression of Bax/Bcl-2 and FOXO4. 2019 1